Today: 8 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Oriental Culture Holding shares rose 1.8% to $0.104 in premarket trading Wednesday after a 23% jump Tuesday, with 342 million shares traded. The company disclosed recent share sales under a $200 million at-the-market program and shareholder approval for a possible reverse split. Traders are watching dilution risk and compliance steps as the stock’s 52-week range spans $0.07 to $19.29.
31 December 2025
·
iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen Inc shares fell about 15% to $0.30 premarket after announcing a $5.5 million private placement of Series C convertible preferred stock. The preferred converts to common shares at a 15% discount to the prior day’s close, raising dilution concerns. The company remains below Nasdaq’s $1 minimum bid, with a compliance deadline of May 2026. Financing is expected to close Wednesday.
31 December 2025
·
Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital Holdings shares jumped about 35% in premarket trading after the company disclosed its special shareholder meeting was adjourned for lack of quorum and rescheduled to Dec. 30. Investors are watching a pending vote on a reverse stock split and share-issuance proposals needed to meet Nasdaq’s $1 minimum bid requirement. The company faces a Jan. 30, 2026 deadline to regain compliance or risk delisting.
31 December 2025
··
Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics shares fell 8.3% to $9.70 premarket after surging 93.8% Tuesday, following Applied Digital’s plan to merge its cloud unit with Ekso to form ChronoScale. The companies signed a non-binding term sheet, with Applied Digital set to own about 97% of the combined firm. Investors await binding terms, financing details, and SEC filings ahead of a shareholder vote.
31 December 2025
···
Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

Oriental Rise Holdings shares rose 36.9% to $1.67 in premarket trading after announcing a non-binding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group. The company did not disclose financial terms and said due diligence is pending. The move follows a 1-for-20 reverse stock split effective Dec. 30. Investors await further details on the deal’s terms, financing, and timeline.
31 December 2025
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

Aimei Health Technology shares jumped 38% to $114 in premarket trading Wednesday, after closing up 89% at $82.58 Tuesday. The surge follows a sharp reduction in outstanding shares after nearly 4 million were redeemed this month, leaving about 2.18 million shares. Trading volume Tuesday was four times the recent average. The company faces a Jan. 6, 2026, deadline to complete its merger with United Hydrogen Group.
31 December 2025
·
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa shares fell about 12% to 10.7 cents in premarket trading Wednesday after a 78% surge the previous day. The company raised the conversion floor on its senior secured convertible notes to $0.35 and eliminated mandatory amortization payments. A filing outlined conditions for up to $5 million in new note financing and referenced a possible reverse stock split in January 2026.
31 December 2025
·
Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharmaceuticals shares rose about 18% in premarket trading after the FDA approved its motion-sickness drug Nereus (tradipitant). The company plans to launch the oral treatment in the coming months. The approval followed late-stage trials involving 681 patients. Shares closed at $7.03 Tuesday and were indicated around $8.30 early Wednesday.
31 December 2025
···
NIO stock steadies in premarket as China rolls out 2026 trade-in subsidies for EVs

NIO stock steadies in premarket as China rolls out 2026 trade-in subsidies for EVs

NIO’s U.S.-listed shares closed up 3% at $5.50 Tuesday on heavy volume, then held steady in early premarket trade as Beijing announced new consumer subsidies for 2026, including up to 20,000 yuan for scrapping old cars and buying new energy vehicles. President Xi Jinping pledged more proactive macro policies next year. XPeng and Li Auto shares also rose.
31 December 2025
···
Stock Market Today: S&P 500 futures slip on New Year’s Eve as Meta’s Manus deal fuels AI chatter

Stock Market Today: S&P 500 futures slip on New Year’s Eve as Meta’s Manus deal fuels AI chatter

S&P 500, Nasdaq 100, and Dow futures slipped early Wednesday, with S&P 500 futures down 0.23% by 2:18 a.m. ET. Meta agreed to acquire Singapore-based AI startup Manus for over $2 billion, according to the Wall Street Journal. Apple and Nvidia led losses among big tech, while energy stocks outperformed. Investors await weekly jobless claims and year-end portfolio rebalancing.
31 December 2025
····
Australian mortgage brokers end 2025 with rate cuts, bank shake-ups and an AI push — here’s what stood out

Australian mortgage brokers end 2025 with rate cuts, bank shake-ups and an AI push — here’s what stood out

Australian mortgage brokers ended 2025 with record market share and momentum from falling interest rates, despite tighter lending rules and increased regulatory scrutiny. Major banks restricted company and trust lending, while ANZ expanded proprietary lending. Industry podcasts tracked themes of technology, broker relevance, and housing outlook. The October–December quarter saw unpredictable lending decisions and regulatory pressure.
31 December 2025
··
1 … 339 340 341 342 343 … 588

Stock Market Today

  • Lilly Shares Rise on Strong Retatrutide Data Boosting Obesity Market Position
    June 8, 2026, 4:36 PM EDT. Eli Lilly's shares surged 4% in premarket trading on Monday following the release of promising new data for retatrutide, its next-generation obesity drug. The data is viewed by analysts and investors as likely to strengthen Lilly's position in the rapidly growing weight-loss market. Retatrutide's performance underscores the company's expanding footprint in obesity treatment, a sector attracting significant medical and commercial interest.

Latest articles

Snap Shares Climb as Debt Markets Send Signal

Snap Drops Again as Wall Street Stays Wary

8 June 2026
Snap plunged 2.1% to $5.64, underperforming a tech rebound, as investors weighed improved cash flow and a recent S&P credit upgrade against ongoing ad-market pressure, cost cuts, and spending on Specs; the stock’s weakness stood out as peers like Pinterest gained, highlighting market doubts about Snap’s ability to sustain growth amid tough competition and uncertain ad budgets.
Dow Drops After Hours, AI Rally Sidesteps Blue Chips

Dow Drops After Hours, AI Rally Sidesteps Blue Chips

8 June 2026
The Dow Jones fell 104.70 points, or 0.21%, to 50,762.08 as tech and chip stocks rebounded sharply, with the Philadelphia SE Semiconductor Index up 6.2% after Friday’s $1 trillion selloff; Apple dropped 1.4% despite its AI event, and investors now await Wednesday’s inflation data and Middle East energy risks as the next key tests for the market’s fragile rebound.
Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

8 June 2026
Tesla shares soared over 5% to $411.66 after a China sales report showed May retail sales up 22.5%, ending a two-month decline, and J.P. Morgan upgraded the stock, citing rising value from autonomy and software; the rally outpaced the Nasdaq as investors bet on Tesla’s China resilience and technology story despite a lofty price-to-earnings ratio of about 378.
Go toTop